A2A Network to add 27 jobs, invest $1.7 million with expansion.
Today, @GovAndyBeshear announced @Alliance_A2A will expand its operations with a new headquarters facility in Scottsville, investing a combined $1.7 million-plus and creating 27 full-time jobs for residents in the community.
Colonel (R) Rondal Turner was one of the many guests who attended the Cover the Cruiser for SOKY Special Olympics athletes.
A2A Alliance Pharmaceuticals Awarded FSS 65IB Contract
The VA NAC (National Acquisition Center) awarded a GSA Schedule 65 I B Drugs, Pharmaceuticals, & Hematology and Pharmaceutical Preparation Manufacturing Contract to A2A Alliance Pharmaceuticals. The Contract has an estimated total valued at $17.3M encompassing 20 Pharmaceutical Products.
KY Governor Announces Infrastructure for New Transpark/A2A Facility
Gov. Beshear awards $5.6 Million administered by the Kentucky Infrastructure Authority (KIA) encompassing ACS-IDA and A2A's New Pharmaceutical Manufacturing Facility
U.S. Military introduced to QuikSal™ - MTOX Collection App as it nears SAMSHA Approval
A2A Alliance Pharmaceuticals and its strategic business network are finalizing approval and implementation for Toxicology for Oral Fluid Collection in conjunction with the US Military and Federal Entities.
Contract Delivery for VISN-20 Completed 1 Month Before Deadline
A2A Alliance Pharmaceuticals successfully delivered a VAMC Contract Award 1 month earlier than deadline. The successfully completed contract was awarded through the Network Contracting Office 20 (NCO). Withstanding the current backlog in Supply Chain issues, A2A delivered a successful contract to a happy customer and cementing A2A's Organizational Values "Highest Quality Standards, Integrity, and Urgency!"
VA Contract Awarded for Albuterol Inhalation Product
Upon successful completion of the previous award, A2A Alliance Pharmaceuticals was awarded a VA Pharmaceutical Contract #36C77022P0220 for Albuterol Sulfate Inhalation.
A2A Alliance Pharmaceuticals was awarded and successfully completed delivery for VA Pharmaceutical Contract #36C77022P0183 for Albuterol Sulfate Inhalation to assist emergency orders.
VA Contract Awarded for Albuterol Inhalation Product
A2A Alliance Pharmaceuticals was awarded a VA Pharmaceutical Contract #36C77022P0183 for Albuterol Sulfate Inhalation.
US Army "Private-Label" Contract Awarded to A2A Alliance Pharmaceuticals
Our unique PPE Kit with the proprietary sanitizer formula was awarded a Private Label contract by the US Army. Following the lead of the US ARNG, COL(R) Rondal Turner, President & CEO, applauds the US Army for recognizing the convenience and importance near and long-term of these PPE Kits.
A2A in Final Stage Plans for New State-of-the-Art Facility
A2A Alliance Pharmaceuticals announces the final stage planning for a new facility to efficiently produce a range of Pharmaceutical and Health related products. The facility will have many capabilities for the wide variety of products that A2A distributes through the Federal Entities. A2A's environmentally conscious initiative's and quality manufacturing processes are the key to creating safe and effective products while emphasizing long-term sustainment. A2A takes that responsibility seriously, with an unwavering commitment.
Digitalization of Supplier Compliance and U.S. Government Regulations
Regulations and Compliance has always been a key component in the U.S. Federal Acquisition and Procurement Process. We have taken an initiative to streamline that compliance with digital technologies.
Department of Defense Pharma Contract Awarded
A2A Alliance Pharmaceuticals is excited to announce a U.S. Department of Defense Contract with the Defense Logistics Agency (DLA) Troop Support for several pharmaceuticals. The start date for this contract is July 31, 2021.
In partnership with ESS Eye Pro, A2A was able to provide a local sheriff department with upgrades to their glasses and sunglasses. Fortunately, the deputy was not injured in the shootout, but was very glad to receive his ballistic glasses after the incident.
Private Labeled ARNG PPE Kit Launch
The product launch of the US ARNG PPE Kit in combination with LIP(USA) and A2A has official product market start date. A2A was able to design, assemble, produce, and deliver within several weeks of the Contract Award date, displaying the efficiency of our capabilities.
DOD/(ARNG) "Private-Label" Contract Awarded to A2A Alliance Pharmaceuticals
Our unique PPE Kit with the proprietary sanitizer formula was awarded a Private Label contract by the US Army National Guard. COL(R) Rondal Turner, President & CEO, applauds the US ARNG for recognizing the convenience and importance near and long-term of these PPE Kits.
Acquisition Technologies Initiated Development
A2A is in the development of a Proprietary Digital Technology initiative that includes a wide scale Machine Learning algorithm for procurement activities of U.S. Federal Health Care Entities.
A2A Alliance Pharmaceuticals accredited VA Certification for SDVOSB
December 16, 2020, U.S. Department of Veterans Affairs (VA), Center for Verification and Evaluation (CVE), accredited and certified A2A Alliance Pharmaceuticals, LLC as a Service-Disabled Veteran-Owned Small Business(SDVOSB) led by Rondal L. Turner, Colonel, U.S. Army (Retired).
eQMS Digital Initiative for FDA Compliance
A2A utilizes the Qualio: Life Sciences Compliance Platform otherwise known as an eQMS, that brings the Quality Management System from traditional regulatory and quality aspects required by the FDA for pharmaceutical manufacturing organizations into the digital “new age”.